Comment on: Prevention of renal damage by treating hyperuricemia

International Journal of Preventive Medicine

Volumn 2015-February, Issue , 2015, Pages

  Nasri, Hamid ^a   Ardalan, Mohammad Reza ^b   Rafieian Kopaei, Mahmoud ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALPHA HYDROXYLASE; 1,25 DIHYDROXYERGOCALCIFEROL; ALLOPURINOL; OXYGENASE; UNCLASSIFIED DRUG; URIC ACID;

BLOOD PRESSURE REGULATION; BODY MASS; DIABETES MELLITUS; DISEASE ASSOCIATION; ELEVATED BLOOD PRESSURE; ENZYME INHIBITION; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY INJURY; LETTER; NONHUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; URIC ACID BLOOD LEVEL; VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

EID: 84930893004     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.151815     Document Type: Letter

References (31)

1. Nickavar A. Prevention of renal damage by treating hyperuricemia. Int J Prev Med 2013;4:1318-20.
2. Nasri H, Rafieian-Kopaei M. Hyperuricemia; a new look at an old problem. J Nephropharmacol 2012;1:13-4.
3. Amiri M, Nasri H. Secondary hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis 2014;2:1-2.
4. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol 2012;1:162-3.
5. Rastegari E, Nasri H. Association of serum leptin with serum C-reactive protein in hemodialysis patients. J Nephropharmacol 2012;1:19-21.
6. Assadi F. The epidemic of pediatric chronic kidney disease: The danger of skepticism. J Nephropathol 2012;1:61-4.
7. Hajivandi A, Amiri M. World Kidney Day 2014: Kidney disease and elderly. J Parathyr Dis 2014;2:3-4.
8. Namjoo AR, MirVakili M, Shirzad H, Faghani M. Biochemical, liver and renal toxicities of Melissa officinals hydroalcoholic extract on balb/C mice. J Herb Med Pharmacol 2013;2:35-40.
9. Behradmanesh S, Horestani MK, Baradaran A, Nasri H. Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci 2013;18:44-6.
10. Rafieian-Kopaei M, Behradmanesh S, Kheiri S, Nasri H. Association of serum uric acid with level of blood pressure in type 2 diabetic patients. Iran J Kidney Dis 2014;8:152-4.
11. Jalalzadeh M, Nurcheshmeh Z, Mohammadi R, Mousavinasab N, Ghadiani MH. The effect of allopurinol on lowering blood pressure in hemodialysis patients with hyperuricemia. J Res Med Sci 2012;17:1039-46.
12. Nasri H, Ardalan MR. Significance of hyperuricemia in immunoglobulin a nephropathy. J Renal Inj Prev 2013;2:105-6.
13. Baradaran A. Primary hyperparathyroidism and kidney; recent findings. J Parathyr Dis 2014;2:5-6.
14. Nasri H. Correlation of serum magnesium with serum levels of 25-hydroxyvitamin D in hemodialysis patients. J Parathyr Dis 2014;2:11-3.
15. Chen W, Roncal-Jimenez C, Lanaspa M, Gerard S, Chonchol M, Johnson RJ, et al. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 2014;63:150-60.
16. Baradaran A. Primary hyperparathyroidism and kidney; recent findings. J Parathyr Dis 2014;2:5-6.
17. Tang Z, Cheng LT, Li HY, Wang T. Serum uric acid and endothelial dysfunction in continuous ambulatory peritoneal dialysis patients. Am J Nephrol 2009;29:368-73.
18. Nasri H. Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes? J Res Med Sci 2013;18:267-8.
19. Kuo CF, Luo SF, See LC, Ko YS, Chen YM, Hwang JS, et al. Hyperuricaemia and accelerated reduction in renal function. Scand J Rheumatol 2011;40:116-21.
20. Nasri H. Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients. J Parathyr Dis 2013;1:13-4.
21. Pickering JW, Endre ZH. The definition and detection of acute kidney injury. J Renal Inj Prev 2014;3:21-5.
22. Juraschek SP, Tunstall-Pedoe H, Woodward M. Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study. Atherosclerosis 2014;233:623-9.
23. Spasovski D. Renal markers for assessment of renal tubular and glomerular dysfunction. J Nephropharmacol 2013;2:23-5.
24. Nasri H. The awareness of chronic kidney disease and aging; the focus of world kidney day in 2014. J Nephropharmacol 2014;3:1-2.
25. Nasri H. Impact of diabetes mellitus on parathyroid hormone in hemodialysis patients. J Parathyr Dis 2013;2:9-11.
26. Rafieian-Kopaei M, Nasri H. Vitamin D therapy in diabetic kidney disease. J Nephropharmacol 2014;3:3-4.
27. Behradmanesh S, Nasri H. Association of serum calcium with level of blood pressure in type 2 diabetic patients. J Nephropathol 2013;2:254-7.
28. Ouppatham S, Bancha S, Choovichian P. The relationship of hyperuricemia and blood pressure in the Thai army population. J Postgrad Med 2008;54:259-62.
29. Nasri H, Rafieian-Kopaei M. Association of serum vitamin D level with age in individuals with normal renal function. J Nephropharmacol 2012;1:7-9.
30. Nasri H, Rafieian-Kopaei M. Significant difference of serum 25-hydroxyvitamin D level in male hemodialysis patients with our without diabetes; a single center study. J Nephropharmacol 2012;1:3-4.
31. Baradaran A. Beyond mineral metabolism, the bright immunomodulatory effect of vitamin D in renal disease. J Nephropharmacol 2012;1:17-8